Finanzwire Finanzwire
Basculer en Français
10820 Companies
234662 Keywords
163523 Articles
125584 Press releases
Headlines Articles Press releases BioXyTran, Inc. Remove
  1. Home
  2. Companies
  3. BioXyTran, Inc.
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 03/02/2026 at 17:45, 5 months 9 days ago

    Bioxytran, Inc. Reports Promising ProLectin-M Study Results

    Clinical Trial COVID-19 Treatment Antiviral Drug BioXyTran ProLectin-M
  • PRESS RELEASE

    published on 03/02/2026 at 17:40, 5 months 9 days ago

    Bioxytran, Inc. Reports Positive Phase 1b/2a Clinical Study Results for ProLectin-M, a Broad-Range Antiviral Drug in Mild to Moderate COVID-19

    Bioxytran, Inc. announces positive results from Phase 1b/2a clinical study evaluating oral ProLectin-M in COVID-19 patients, showing earlier viral clearance, clinical improvement, and safety
    COVID-19 Clinical Study Antiviral ProLectin-M Bioxytran Inc.
    Logo of BioXyTran, Inc.
Accesswire
  • Published on 08/12/2026 at 00:00, 7 hours 21 minutes ago

    Organto Foods Reports Record Second Quarter 2026 Financial Results

  • Published on 08/11/2026 at 23:40, 7 hours 41 minutes ago

    RJK Explorations Ltd. Announces Private Placement for Gross Proceeds of up to $100,000

  • Published on 08/11/2026 at 23:15, 8 hours 6 minutes ago

    Fermi and Hillcore Energy Capital Announce 2.6 Gigawatt Power Strategic Alliance for Project Matador

  • Published on 08/11/2026 at 23:00, 8 hours 21 minutes ago

    Prospectiva Resources Ltd. Completes Qualifying Transaction

  • Published on 08/11/2026 at 22:55, 8 hours 26 minutes ago

    NV Gold Announces Non-Brokered Private Placement

View all ACCESSWIRE
EQS Group
  • Published on 08/12/2026 at 07:10, 11 minutes ago

    Deutsche Konsum Real Estate AG publishes quarterly statement for the first nine months of the 2025/2026 financial year

  • Published on 08/12/2026 at 07:00, 21 minutes ago

    MindMaze Therapeutics Appoints Prof. John W. Krakauer as Strategic Advisor

  • Published on 08/12/2026 at 07:00, 21 minutes ago

    SCHOTT Pharma with strong third quarter and on track for planned growth

  • Published on 08/12/2026 at 07:00, 21 minutes ago

    TUI delivered resilient Q3 underlying EBIT of €234.6m (at CC), demonstrating the strength of its business despite geopolitical headwinds and one-offs, FY26 guidance reaffirmed

  • Published on 08/12/2026 at 07:00, 21 minutes ago

    E.ON remains on track and continues to invest in the energy transition

View all EQS
Les Echos
  • Published on 08/10/2026 at 18:00, 1 day 13 hours ago

    AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026

  • Published on 08/10/2026 at 17:45, 1 day 13 hours ago

    Weekly share buyback

  • Published on 08/10/2026 at 11:53, 1 day 19 hours ago

    GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026

  • Published on 08/10/2026 at 11:36, 1 day 19 hours ago

    GUILLEMOT CORPORATION| Weekly report share buyback from August 3 to August 7 2026

  • Published on 08/10/2026 at 09:22, 1 day 21 hours ago

    Number of shares and voting rights - July 2026 (In French only)

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy